Perioperative blood transfusion as a significant predictor of biochemical recurrence and survival after radical prostatectomy in patients with prostate cancer

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Kim, Jung Kwon ^a   Kim, Hyung Suk ^a   Park, Juhyun ^a   Jeong, Chang Wook ^a   Ku, Ja Hyeon ^a   Kim, Hyun Hoe ^a   Kwak, Cheol ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CANCER LOCALIZATION; CANCER SPECIFIC SURVIVAL; CONTROLLED STUDY; HUMAN; KAPLAN MEIER METHOD; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE BLOOD TRANSFUSION; PERIOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TUMOR RECURRENCE;

AGED; BLOOD TRANSFUSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84969884766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154918     Document Type: Article

References (35)

1. Buddeberg F, Schimmer BB, Spahn DR. Transfusion-transmissible infections and transfusion-related immunomodulation. Best Pract Res Clin Anaesthesiol 2008 Sep; 22(3):503-17. PMID: 18831300
2. Amato A, Pescatori M. Perioperative blood transfusions and recurrence of colorectal cancer. Cochrane Database Syst Rev 2006 Jan 25(1):CD005033.
3. Motoyama S, Okuyama M, Kitamura M, Saito R, Kamata S, Murata K, et al. Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer. J Surg oncol 2004 Jul; 87(1):26-31. PMID: 15221916
4. Wang CC, Iyer SG, Low JK, Lin C, Wang S, Lu SN, et al. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2009 Jul; 16(7):1832-42. doi: 10.1245/s10434-009-0448-y PMID: 19365625
5. Lloyd JC, Bañez LL, Aronson WJ, Terris MK, Presti JJ, Amling CL, et al. Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH database. BJU Int 2010 Feb; 105(3):347-51. doi: 10.1111/j.1464-410X.2009.08792.x PMID: 19709073
6. Oefelein MG, Colangelo LA, Rademaker AW, McVary KT. Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol 1995 Aug; 154(2 Pt 1):442-7. PMID: 7609106
7. Paul R, Schmid R, Busch R, van Randenborgh H, Alschibaja M, Scholer S, et al. Influence of blood transfusions during radical retropubic prostatectomy on disease outcome. Urology 2006 Jan; 67(1):137-41. PMID: 16413349
8. Ford BS, Sharma S, Rezaishiraz H, Huben RS, Mohler JL. Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol 2008 Jul-Aug; 26(4):364-7 doi: 10.1016/j.urolonc.2007.06.004 PMID: 18367097
9. Heal JM, Chuang C, Blumberg N. Perioperative blood transfusions and prostate cancer recurrence and survival. Am J Surg 1988 Nov; 156(5):374-80. PMID: 3189708
10. Jakobsen E, Eickhoff J, Andersen J, Ottesen M. Perioperative blood transfusion does not affect survival after operation for renal cell cancer. Eur Urol 1994; 26(2):145-8. PMID: 7957470
11. Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, et al. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC). BJU Int 2014 Sep; 114(3):368-74. doi: 10.1111/bju.12535 PMID: 24471825
12. Jahnson S, Bergström R, Pedersen J. Extent of blood transfusion and cancer-related mortality after cystectomy and urinary diversion for bladder cancer. Br J Urol 1994 Dec; 74(6):779-84. PMID: 7827851
13. Morgan TM, Barocas DA, Chang SS, Phillips SE, Salem S, Clark PE, et al. The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol Oncol 2013 Aug; 31(6):871-7. doi: 10.1016/j.urolonc.2011.07.012 PMID: 21906965
14. Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013 May; 63(5):839-45. doi: 10.1016/j.eururo.2013.01.004 PMID: 23332883
15. Gallina A, Briganti A, Chun FKH, Walz J, Hutterer GC, Erbersdobler A, et al. Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy. BJU Int 2007 Dec; 100(6):1249-53. PMID: 17850374
16. Ness P, Walsh P, Zahurak M, Baldwin M, Piantadosi S. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion 1992 Jan; 32(1):31-6. PMID: 1370592
17. Velagapudi SR, Frydenberg M, Oesterling JE, Bergstralh EJ, Moore SB, Ruckle HC, et al. Homologous blood transfusion in patients with prostate cancer: no effect on tumor progression or survival. Urology 1994 Jun; 43(6):821-7. PMID: 8197646
18. Boehm K, Beyer B, Tennstedt P, Schiffmann J, Budaeus L, Haese A, et al. No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer. World J Urol 2015 Jun; 33(6):801-6. doi: 10.1007/s00345-014-1351-0 PMID: 24989847
19. Yeoh TY, Scavonetto F, Weingarten TN, Karnes RJ, van Buskirk CM, Hanson AC, et al. Perioperative allogeneic nonleukoreduced blood transfusion and prostate cancer outcomes after radical prostatectomy. Transfusion 2014 Sep; 54(9):2175-81. doi: 10.1111/trf.12595 PMID: 24660833
20. Davies A, Ramarakha P, Cranston D, Clarke PJ. Effect of blood transfusion on survival after radiotherapy as treatment for carcinoma of the prostate. Ann R Coll Surg Engl 1991 Mar; 73(2):116-8. PMID: 2018314
21. McClinton S, Moffat L, Scott S, Urbaniak S, Kerridge D. Blood transfusion and survival following surgery for prostatic carcinoma. Br J Surg 1990 Feb; 77(2):140-2. PMID: 2317671
22. Chalfin HJ, Frank SM, Feng Z, Trock BJ, Drake CG, Partin AW, et al. Allogeneic versus autologous blood transfusion and survival after radical prostatectomy. Transfusion 2014 Sep; 54(9):2168-74. doi: 10.1111/trf.12611 PMID: 24601996
23. Soubra A, Zabell JR, Adejoro O, Konety BR. Effect of Perioperative Blood Transfusion on Mortality for Major Urologic Malignancies. Clin Genitourin Cancer 2015 Jun; 13(3):e173-81. doi: 10.1016/j.clgc.2014.12.006 PMID: 25600760
24. Korets R, Weinberg AC, Alberts BD, Woldu SL, Mann MJ, Badani KK. Utilization and Timing of Blood Transfusions Following Open and Robot-Assisted Radical Prostatectomy. J Endourol 2014 Dec; 28(12):1418-23. doi: 10.1089/end.2014.0225 PMID: 25333318
25. Novara G, Ficarra V, Rosen RC, Artibani W, Costello A, Eastham JA, et al. Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. Eur Urol 2012 Sep; 62(3):431-52. doi: 10.1016/j.eururo.2012.05.044 PMID: 22749853
26. Tewari A, Sooriakumaran P, Bloch DA, Seshadri-Kreaden U, Hebert AE, Wiklund P. Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol 2012 Jul; 62(1):1-15. doi: 10.1016/j.eururo.2012.02.029 PMID: 22405509
27. Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, et al. Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg 2009 Oct; 13(10):1821-30. doi: 10.1007/s11605-009-0973-9 PMID: 19655208
28. Shiba H, Ishida Y, Wakiyama S, Iida T, Matsumoto M, Sakamoto T, et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 2009 Sep; 13(9):1636-42. doi: 10.1007/s11605-009-0963-y PMID: 19582515
29. Liewald F, Wirsching R, Zülke C, Demmel N, Mempel W. Influence of blood transfusions on tumor recurrence and survival rate in colorectal carcinoma. Eur J Cancer 1990 Mar; 26(3):327-35. PMID: 2141490
30. Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, et al. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur Urol 2014 Dec; 66(6):1139-47. doi: 10.1016/j.eururo.2014.08.051 PMID: 25194909
31. Enqel O, Soave A, Peine S, Kluth LA, Schmid M, Shariat SF, et al. The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. World J Urol 2015 Nov; 33(11):1769-76. doi: 10.1007/s00345-015-1531-6 PMID: 25782867
32. Moschini M, Bianchi M, Rossi MS, Dell'Oqlio P, Gandaqlia G, Fossati N, et al. Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. Urol Oncol 2016 Feb 2. pii: S1078-1439(15)00612-2. doi: 10.1016/j.urolonc.2015.12.016 [Epub ahead of print].
33. Tollefson MK, Karnes RJ, Ranqel L, Carlson R, Boorjian SA. Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy. J Urol 2014 Mar; 191(3):646-51. doi: 10.1016/j.juro.2013.10.062 PMID: 24140843
34. Chhatre S, Bruce Malkowicz S, Sanford Schwartz J, Jayadevappa R. Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE). Medicine (Baltimore) 2015 Aug; 94(32):e1353.
35. Prasad SM, Keating NL, Wang Q, Pashos CL, Lipsitz S, Richie JP, et al. Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy. Urology 2008 Sep; 72(3):647-52. doi: 10.1016/j.urology.2008.03.067 PMID: 18649928